Driving reinvestment in R&D for antibiotics and advocating their responsible use

Tag Archives: DRIVE-AB

Registration Now Open: Final DRIVE-AB Conference

Posted on by in News

Revitalizing the Antibiotic Pipeline

Stimulating innovation while driving sustainable use and global access 5-6 September 2017, Crowne Plaza, Brussels

Registration for the final DRIVE-AB conference is now open. Aimed at global policy and decision makers, regulatory and public health experts, economists and representatives of the pharmaceutical, medical and civil society communities, the purpose of the conference is to:
  1. communicate the consortium’s final recommendations and
  2. work with stakeholders towards implementing them worldwide.
For more information and to view the programme, please see the conference website. If you are...
Read moreComments are closed

DRIVE-AB Symposium at 17th International Congress on Infectious Diseases

Posted on by in News
The 17th International Congress on Infectious Diseases (ICID) is taking place in Hyderabad, India, from March 2-5, 2016. This year DRIVE-AB will be collaborating on a symposium titled, "New and recently approved antibiotics: Challenges and opportunities". The symposium will take place on Saturday, March 5 in Hall 2 from 10:15 - 12:15hrs and will be co-chaired by R. Rangarajan (India) and DRIVE-AB participant U. Theuretzbacher (Austria). Another DRIVE-AB participant, C. Årdal (Norway), will be giving a presentation during the symposium  on "Incentivising antibiotic innovation". New and Recently Approved Antibiotics: Challenges and Opportunities (in collaboration with DRIVE-AB- a project of the Innovative Medicines Initiative) Saturday,...
Read moreComments are closed